![Ronald Pepin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Pepin
Corporate Officer/Principal bei
CELLDEX THERAPEUTICS, INC.
Vermögen: 631 649 $ am 31.05.2026
Profil
Ronald A. Pepin is Director at Antyra, Inc. Dr. Pepin is Chief Business Officer & Senior Vice President at Celldex Therapeutics, Inc. since 2011.
Dr. Pepin was Executive Director-External Science & Technology at Bristol Myers Squibb Co. from 1990 to 2000.
Dr. Pepin was Senior Vice President-Business Development at Medarex, Inc. from 2000 to 2009.
Dr. Pepin was Vice President at Shire Pharmaceuticals, Inc. Dr. Pepin completed undergraduate studies at Tufts University.
Dr. Pepin earned a doctorate from Georgetown University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.06.2026 | 20’097 ( 0.03% ) | 631 649 $ | 31.05.2026 |
Aktive Positionen von Ronald Pepin
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 08.07.2011 |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ronald Pepin
| Unternehmen | Position | Ende |
|---|---|---|
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 01.01.2009 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2000 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Ronald Pepin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Wählen Sie MarketScreener 
